1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-7 of 7 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2021Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancerLin, H.-M.; Huynh, K.; Kohli, M.; Tan, W.; Azad, A.A.; Yeung, N.; Mahon, K.L.; Mak, B.; Sutherland, P.D.; Shepherd, A.; Mellett, N.; Docanto, M.; Giles, C.; Centenera, M.M.; Butler, L.M.; Meikle, P.J.; Horvath, L.G.
2020Fatty acid oxidation is an adaptive survival pathway induced in prostate tumors by heat shock protein 90 inhibitionNassar, Z.D.; Mah, C.Y.; Centenera, M.M.; Irani, S.; Sadowski, M.C.; Scott, J.S.; Nguyen, E.V.; Nagarajan, S.R.; Moldovan, M.; Lynn, D.J.; Daly, R.J.; Hoy, A.J.; Butler, L.M.
2021Lipidomic profiling of clinical prostate cancer reveals targetable alterations in membrane lipid compositionButler, L.M.; Mah, C.Y.; Machiels, J.; Vincent, A.D.; Irani, S.; Mutuku, S.; Spotbeen, X.; Bagadi, M.; Waltregny, D.; Moldovan, M.; Dehairs, J.; Vanderhoydonc, F.; Bloch, K.; Das, R.; Stahl, J.; Kench, J.G.; Gevaert, T.; Derua, R.; Waelkens, E.; Nassar, Z.D.; et al.
2020Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)Scheinberg, T.; Kench, J.; Stockler, M.; Mahon, K.L.; Sebastian, L.; Stricker, P.; Joshua, A.M.; Woo, H.; Thanigasalam, R.; Ahmadi, N.; Centenera, M.M.; Butler, L.M.; Horvath, L.G.
2023Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancerHinneh, J.A.; Gillis, J.L.; Mah, C.Y.; Irani, S.; Shrestha, R.K.; Ryan, N.K.; Atsushi, E.; Nassar, Z.D.; Lynn, D.J.; Selth, L.A.; Kato, M.; Centenera, M.M.; Butler, L.M.
2021A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growthGillis, J.L.; Hinneh, J.A.; Ryan, N.K.; Irani, S.; Moldovan, M.; Quek, L.-E.; Shrestha, R.; Hanson, A.R.; Xie, J.; Hoy, A.J.; Holst, J.; Centenera, M.M.; Mills, I.G.; Lynn, D.J.; Selth, L.A.; Butler, L.M.
2022Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate CancerAlizadeh-Ghodsi, M.; Owen, K.L.; Townley, S.L.; Zanker, D.; Rollin, S.P.G.; Hanson, A.R.; Shrestha, R.; Toubia, J.; Gargett, T.; Chernukhin, I.; Luu, J.; Cowley, K.J.; Clark, A.; Carroll, J.S.; Simpson, K.J.; Winter, J.M.; Lawrence, M.G.; Butler, L.M.; Risbridger, G.P.; Thierry, B.; et al.

Discover